Coma chetoacidosico

Translated title of the contribution: Diabetic ketoacidosis

C. Bizzarri, G. Marietti, A. Tempera

Research output: Contribution to journalArticle

Abstract

Despite many advances in the overall treatment of type 1 diabetes mellitus during the last few years, no maior advance has been made in decreasing the mortality rate of diabetic ketoacidosis. A mayor concern is the development of cerebral edema during treatment. The guiding principles of therapy are rehydration, electrolyte replacement, insulin therapy, and treatment of any underlying illnesses. If the patient is in shock, therapy begins with colloids or normal saline administration to support blood pressure. Fluid and electrolyte deficits should be calculated and replaced during 48 hours. Low dose insulin infusion is employed for treatment of hyperglycemia. Neurologic function should be carefully monitored and mannitol administered immediately if cerebral edema is suspected.

Original languageItalian
Pages (from-to)253-261
Number of pages9
JournalActa Medica Romana
Volume37
Issue number1-2
Publication statusPublished - 1999

Fingerprint

Diabetic Ketoacidosis
Brain Edema
Electrolytes
Therapeutics
Insulin
Convulsive Therapy
Fluid Therapy
Colloids
Mannitol
Type 1 Diabetes Mellitus
Hyperglycemia
Nervous System
Blood Pressure
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Bizzarri, C., Marietti, G., & Tempera, A. (1999). Coma chetoacidosico. Acta Medica Romana, 37(1-2), 253-261.

Coma chetoacidosico. / Bizzarri, C.; Marietti, G.; Tempera, A.

In: Acta Medica Romana, Vol. 37, No. 1-2, 1999, p. 253-261.

Research output: Contribution to journalArticle

Bizzarri, C, Marietti, G & Tempera, A 1999, 'Coma chetoacidosico', Acta Medica Romana, vol. 37, no. 1-2, pp. 253-261.
Bizzarri C, Marietti G, Tempera A. Coma chetoacidosico. Acta Medica Romana. 1999;37(1-2):253-261.
Bizzarri, C. ; Marietti, G. ; Tempera, A. / Coma chetoacidosico. In: Acta Medica Romana. 1999 ; Vol. 37, No. 1-2. pp. 253-261.
@article{49fac08e4b704efc9210cf4bf0d9573e,
title = "Coma chetoacidosico",
abstract = "Despite many advances in the overall treatment of type 1 diabetes mellitus during the last few years, no maior advance has been made in decreasing the mortality rate of diabetic ketoacidosis. A mayor concern is the development of cerebral edema during treatment. The guiding principles of therapy are rehydration, electrolyte replacement, insulin therapy, and treatment of any underlying illnesses. If the patient is in shock, therapy begins with colloids or normal saline administration to support blood pressure. Fluid and electrolyte deficits should be calculated and replaced during 48 hours. Low dose insulin infusion is employed for treatment of hyperglycemia. Neurologic function should be carefully monitored and mannitol administered immediately if cerebral edema is suspected.",
author = "C. Bizzarri and G. Marietti and A. Tempera",
year = "1999",
language = "Italian",
volume = "37",
pages = "253--261",
journal = "Acta Medica Romana",
issn = "0001-6098",
publisher = "Vita e Pensiero",
number = "1-2",

}

TY - JOUR

T1 - Coma chetoacidosico

AU - Bizzarri, C.

AU - Marietti, G.

AU - Tempera, A.

PY - 1999

Y1 - 1999

N2 - Despite many advances in the overall treatment of type 1 diabetes mellitus during the last few years, no maior advance has been made in decreasing the mortality rate of diabetic ketoacidosis. A mayor concern is the development of cerebral edema during treatment. The guiding principles of therapy are rehydration, electrolyte replacement, insulin therapy, and treatment of any underlying illnesses. If the patient is in shock, therapy begins with colloids or normal saline administration to support blood pressure. Fluid and electrolyte deficits should be calculated and replaced during 48 hours. Low dose insulin infusion is employed for treatment of hyperglycemia. Neurologic function should be carefully monitored and mannitol administered immediately if cerebral edema is suspected.

AB - Despite many advances in the overall treatment of type 1 diabetes mellitus during the last few years, no maior advance has been made in decreasing the mortality rate of diabetic ketoacidosis. A mayor concern is the development of cerebral edema during treatment. The guiding principles of therapy are rehydration, electrolyte replacement, insulin therapy, and treatment of any underlying illnesses. If the patient is in shock, therapy begins with colloids or normal saline administration to support blood pressure. Fluid and electrolyte deficits should be calculated and replaced during 48 hours. Low dose insulin infusion is employed for treatment of hyperglycemia. Neurologic function should be carefully monitored and mannitol administered immediately if cerebral edema is suspected.

UR - http://www.scopus.com/inward/record.url?scp=0033044407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033044407&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0033044407

VL - 37

SP - 253

EP - 261

JO - Acta Medica Romana

JF - Acta Medica Romana

SN - 0001-6098

IS - 1-2

ER -